Page last updated: 2024-09-03

rubimaillin and Bowel Diseases, Inflammatory

rubimaillin has been researched along with Bowel Diseases, Inflammatory in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, HG; Kim, JA; Kim, KJ; Kwak, MK; Lee, JS; Lee, YR; Lyoo, WS; Park, YJ; Yong, CS	1

Other Studies

1 other study(ies) available for rubimaillin and Bowel Diseases, Inflammatory

Article	Year
Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF-kappaB activation. European journal of pharmacology, 2009, Nov-10, Volume: 622, Issue:1-3 Topics: Animals; Anti-Inflammatory Agents; Cattle; Cell Adhesion; Chemokines; Colon; Epithelial Cells; Gene Expression Regulation; HT29 Cells; Humans; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; NF-kappa B; Pyrans; Tumor Necrosis Factor-alpha; U937 Cells	2009

Article

Year

Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF-kappaB activation.

European journal of pharmacology, 2009, Nov-10, Volume: 622, Issue:1-3

Topics: Animals; Anti-Inflammatory Agents; Cattle; Cell Adhesion; Chemokines; Colon; Epithelial Cells; Gene Expression Regulation; HT29 Cells; Humans; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; NF-kappa B; Pyrans; Tumor Necrosis Factor-alpha; U937 Cells

2009